You limited your search to:

 Decade: 2000-2009
 Year: 2000
 Collection: Congressional Research Service Reports
Patent Ownership and Federal Research and Development (R and D): A Discussion on the Bayh-Dole Act and the Stevenson-Wydler Act
No Description digital.library.unt.edu/ark:/67531/metacrs1294/
Asset Distribution of Taxable Estates: An Analysis
This report provides data on the distribution of assets in taxable estates that filed returns in 1998. The report also offers a brief overview of the estate and gift tax and "The Death Tax Elimination Act of 2000," which was passed in the 106th Congress and vetoed. This report finds that farm and business assets represent a small share of the total value of taxable estate tax returns filed in 1998. For an overview of estate tax, see CRS Report RL30600, Estate and Gift Taxes: Economic Issues, by Jane G. Gravelle and Steven Maguire. This report will be updated as new data becomes available. digital.library.unt.edu/ark:/67531/metacrs1325/
R&D Partnerships and Intellectual Property: Implications for U.S. Policy
No Description digital.library.unt.edu/ark:/67531/metacrs1254/
Technology Transfer: Use of Federally Funded Research and Development
No Description digital.library.unt.edu/ark:/67531/metacrs1319/
Point and Click: Internet Search Engines, Subject Guides, and Searching Techniques
No Description digital.library.unt.edu/ark:/67531/metacrs1318/
Research and Development: Priority Setting and Consolidation in Science Budgeting
No Description digital.library.unt.edu/ark:/67531/metacrs1293/
Manipulating Molecules: The National Nanotechnology Initiative
No Description digital.library.unt.edu/ark:/67531/metacrs1324/
Stem Cell Research
No Description digital.library.unt.edu/ark:/67531/metacrs1270/
The National Institutes of Health: An Overview
The National Institutes of Health is the focal point of federal health research. It uses its $17.8 billion budget to support more than 50,000 scientists working at 2,000 institutions across the United States, as well as to conduct biomedical and behavioral research and research training at its own facilities. digital.library.unt.edu/ark:/67531/metadc26108/
NASA's Earth Science Enterprise
No Description digital.library.unt.edu/ark:/67531/metacrs1216/
An Examination of the Issues Surrounding Biotechnology Patenting and Its Effect Upon Entrepreneurial Companies
The biotechnology industry is notable both for its heavy concentration of small businesses and its weighty research and development (R&D) expenditures. Given the small size and heavy expenses of many biotechnology firms, their ability to raise venture capital may be of some consequence. The patent law has been identified as a facilitator of these R&D financing efforts. Congress may choose to exercise oversight on these issues. Such consideration would likely include examination of U.S. commitments in international agreements along with other factors. digital.library.unt.edu/ark:/67531/metacrs1296/
How to Find Information in a Library
No Description digital.library.unt.edu/ark:/67531/metacrs1250/
Daylight Saving Time
Currently, in most parts of the United States, timepieces are moved forward one hour in the spring and back one hour in the fall to provide an extended daylight period during the summer months. This is known as Daylight Saving Time (DST). Much debate and many changes led to this present practice. This report provides a brief history of the issues surrounding DST, an outline of the legislation that created and modified it, and a list of references to more discussions. digital.library.unt.edu/ark:/67531/metacrs1292/
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship
Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress. digital.library.unt.edu/ark:/67531/metacrs1092/
Global Climate Change: A Survey of Scientific Research and Policy Reports
This report is intended to guide the reader through U.S. global climate change policy from the passage of the National Climate Program Act of 1978 (P.L. 95-367) through the 1992 Earth Summit in Rio de Janeiro, where the U.N. Framework Convention on Climate Change (FCCC) was opened for signatures. It offers a summary of scientific research on global climate change and related U.S. policy and identifies what many consider to be important milestones in the international policy debate on global climate change. digital.library.unt.edu/ark:/67531/metacrs1071/
Grants Information on the World Wide Web
No Description digital.library.unt.edu/ark:/67531/metacrs1297/
Science, Technology, and Medicine: Issues Facing the 106th Congress, Second Session
No Description digital.library.unt.edu/ark:/67531/metacrs1295/